Developing patient‐centered informed consent processes for deciding whether to accept intervention organs and participating in organ donor intervention research is essential for protecting transplant candidates’ autonomy.¹ Richard Freeman’s letter is highly encouraging given his appreciation for the value patients placed on informed consent for intervention organs, and for recognizing the feasibility of implementing research and clinical informed consent into clinical practice, even in urgent contexts.²

中文翻译：

---

器官捐献者干预研究知情同意 - 时间和风险。

制定以患者为中心的知情同意程序来决定是否接受干预器官和参与器官供体干预研究对于保护移植候选人的自主权至关重要。¹理查德·弗里曼 (Richard Freeman) 的信非常鼓舞人心，因为他赞赏患者对干预器官的知情同意的重视，并认识到即使在紧急情况下也能在临床实践中实施研究和临床知情同意的可行性。^2个